At the GWCC, the safety of our members, staff and in particular our cancer patients, many of whom are immunocompromised, is a top priority. In the setting of the COVID-19 pandemic, we understand that our cancer patients may have more concerns than the general population about contracting the virus. Review the General Guidance for Patients.
The Gastrointestinal Cancers Program at the George Washington University (GW) Cancer Center offers a multidisciplinary, team-based approach to care. We are a national leader in cutting-edge clinical care and innovative research. Learn more about why it matters for patients and what makes the GW Cancer Center unique.
The George Washington (GW) Cancer Center is a collaboration between GW Hospital, The GW Medical Faculty Associates, and the GW School of Medicine and Health Sciences to expand GW’s efforts in the fight against cancer. The GW Cancer Center also partners with the Milken Institute School of Public Health at GW, and incorporates all existing cancer-related activities at GW, serving as a platform for future cancer services and research development.
The GW Cancer Center boasts state-of-the-art research facilities dedicated to cancer discovery through interdisciplinary collaboration with scientists and clinicians throughout GW.
We are pleased that you have selected the GW Cancer Center to provide your cancer care and support. The information found here will acquaint you with available information and resources.
The GW Cancer Center provides a comprehensive range of research education and career development programs designed to equip the next generation of scientists and health care providers.
My doctors at GW Cancer Center saved my life more than once.
GW has been the best place for me, my family, and my condition.
My family and I are so grateful to my GW team for their care and compassion.
The ongoing corporate research partnership between SEAS Professor Michael Keidar and the biotech company US Patent Innovations, LLC employs engineering and translational molecular sciences to develop new medical devices
WASHINGTON (Aug. 5, 2020) — Genetic modifier HDAC6 was found to control tumor growth and halt metastasis in triple-negative breast cancer in vivo, according to a new study published in the top-tier journal Cancer Research by investigators at the George Washington University (GW) Cancer Center.
WASHINGTON (July 16, 2020) – The National Institutes of Health has awarded $3.6 million to ...
Knowing what cancer survivors value can help providers address gaps in care, improve the care experience, and increase behaviors and practices that support survivors’ ability to accept and manage their post-treatment care, according to focus group findings from researchers at the George...
WASHINGTON (July 9, 2020) — Recognized cancer prevention and control expert Elmer E. Huerta, MD, MPH, will serve as the director of the Cancer Preventorium at the George Washington University (GW) Cancer Center and as professor of medicine at the GW School of Medicine and Health Sciences. ...
Experts at the George Washington University (GW) School of Medicine and Health Sciences are available to comment on stories around Breast Cancer Awareness Month. Experts are available to comment on “stage 0” breast cancer diagnosis, personalized medicine, survivorship, trends in breast cancer care and treatment, and more.
At the GW Cancer Center, we believe we have a responsibility to work toward health equity. Whether at the patient’s bedside or crunching data in a lab, connection with the communities we serve forms the foundation of everything we do.
That’s why we chose “re:connect” as the theme of this issue — it’s part of our mission to listen, understand, and address many of the problems that are unique to our region so that, ultimately, we see progress against cancer at a population level. Read Full Magazine
Accessibility Notice: GW is committed to and is working towards accessibility for all. If you experience an access barrier, please let us know via the .
